Cera Biologicals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 42.11%
- Profit Growth 26.96%
- Ebitda -198.71%
- Net Worth 32.96%
- Total Assets -3.21%
About Cera Biologicals India
Cera Biologicals India Private Limited (CBIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 May 2015 (Nine years and eight months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Nallagonda and Paturu Madhavi serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2015PTC099021
-
Company No.
099021
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 May 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Cera Biologicals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Nallagonda
|
Director | 21-May-2015 | Current |
|
Paturu Madhavi
|
Director | 21-May-2015 | Current |
Financial Performance of Cera Biologicals India.
Cera Biologicals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.11% increase. The company also saw a substantial improvement in profitability, with a 26.96% increase in profit. The company's net worth Soared by an impressive increase of 32.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cera Biologicals India?
In 2021, Cera Biologicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sri Jagannadh Swami Health Care Private LimitedRavindra Nallagonda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cera Biologicals India?
Unlock and access historical data on people associated with Cera Biologicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cera Biologicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cera Biologicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.